Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    March 2019

  1. Effect of wound complications following mastectomy with reconstruction on breast cancer recurrence.
    Am J Surg. 2019;217:519.
    PubMed     Text format    



  2. The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2019;217:478.
    PubMed     Text format    


    January 2019
  3. CHATTERJEE A, Asban A, Jonczyk M, Chen L, et al
    A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer.
    Am J Surg. 2019 Jan 31. pii: S0002-9610(18)31174.
    PubMed     Text format     Abstract available


  4. SATYANANDA V, Ozao-Choy J, Dauphine C, Chen KT, et al
    Effect of the Affordable Care Act on breast cancer presentation at a safety net hospital.
    Am J Surg. 2019 Jan 17. pii: S0002-9610(18)31369.
    PubMed     Text format     Abstract available


    November 2018
  5. BURKHEIMER E, Starks L, Khan M, Oostendorp L, et al
    The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2018 Nov 14. pii: S0002-9610(18)30972.
    PubMed     Text format     Abstract available


    October 2018
  6. VALENTE SA, Liu Y, Upadhyaya S, Tu C, et al
    The effect of wound complications following mastectomy with immediate reconstruction on breast cancer recurrence.
    Am J Surg. 2018 Oct 16. pii: S0002-9610(18)31027.
    PubMed     Text format     Abstract available


    September 2018
  7. PUGH AM, Giannini CM, Pinney SM, Hanseman DJ, et al
    Characteristics and diagnosis of pregnancy and lactation associated breast cancer: Analysis of a self-reported regional registry.
    Am J Surg. 2018 Sep 20. pii: S0002-9610(18)30115.
    PubMed     Text format     Abstract available


    August 2018
  8. WAZIR U, Mokbel L, Wazir A, Mokbel K, et al
    Optimizing adjuvant endocrine therapy for early ER+ breast cancer: An update for surgeons.
    Am J Surg. 2018 Aug 3. pii: S0002-9610(18)30269.
    PubMed     Text format     Abstract available


    July 2018
  9. NAYYAR A, Strassle PD, Shen MR, Black JA, et al
    Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
    Am J Surg. 2018 Jul 24. pii: S0002-9610(18)30024.
    PubMed     Text format     Abstract available


  10. SCHWARTZBERG BS, Chin DT, Dorn PL, Herron DS, et al
    Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
    Am J Surg. 2018 Jul 19. pii: S0002-9610(18)30097.
    PubMed     Text format     Abstract available


  11. PARVEZ E, Cornacchi SD, Fu E, Hodgson N, et al
    Adoption and outcomes of radioguided seed localization for non-palpable invasive and in-situ breast cancer at three academic tertiary care centers.
    Am J Surg. 2018 Jul 9. pii: S0002-9610(18)30445.
    PubMed     Text format     Abstract available


    April 2018
  12. PARK VY, Kim EK, Moon HJ, Yoon JH, et al
    Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.
    Am J Surg. 2018 Apr 21. pii: S0002-9610(17)31185.
    PubMed     Text format     Abstract available


  13. CANDELARIA RP, Hansakul P, Thompson AM, Le-Petross H, et al
    Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?
    Am J Surg. 2018;215:693-698.
    PubMed     Text format     Abstract available


  14. KOZICK Z, Hashmi A, Dove J, Hunsinger M, et al
    Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment.
    Am J Surg. 2018;215:686-692.
    PubMed     Text format     Abstract available


    March 2018
  15. MASSIMINO K
    Discussion of: "Pre-surgical chemotherapy for breast cancer may be associated with improved outcome".
    Am J Surg. 2018 Mar 20. pii: S0002-9610(17)31659.
    PubMed     Text format    


  16. JOHNSON N
    Discussion of: Routine shave margins are not necessary in early stage breast cancer treated with breast conserving surgery.
    Am J Surg. 2018 Mar 20. pii: S0002-9610(18)30404.
    PubMed     Text format    


  17. COOK M, Johnson N
    Pre-surgical chemotherapy for breast cancer may be associated with improved outcomes.
    Am J Surg. 2018 Mar 16. pii: S0002-9610(17)31537.
    PubMed     Text format     Abstract available


  18. WILSON LL
    LaSalle D. Leffall and disparities in breast cancer.
    Am J Surg. 2018 Mar 7. pii: S0002-9610(18)30343.
    PubMed     Text format    



  19. Discussion of: Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2018;215:513-514.
    PubMed     Text format    



  20. Discussion of: A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:404-405.
    PubMed     Text format    


  21. KUPSTAS A, Ibrar W, Hayward RD, Ockner D, et al
    A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:400-403.
    PubMed     Text format     Abstract available


    February 2018
  22. WARREN SL, Bhutiani N, Agle SC, Martin RCG 2nd, et al
    Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer.
    Am J Surg. 2018 Feb 17. pii: S0002-9610(17)31373.
    PubMed     Text format     Abstract available


  23. DEBARROS M
    The significance and impact of pathogenic and variants of unknown significance (VUS) mutations in breast cancer patients and their treatment decisions.
    Am J Surg. 2018 Feb 15. pii: S0002-9610(17)31692.
    PubMed     Text format    


  24. HENRY-TILLMAN RS
    The tale of two stories: Challenges and innovations in breast cancer management.
    Am J Surg. 2018 Feb 1. pii: S0002-9610(17)31767.
    PubMed     Text format     Abstract available


    January 2018
  25. PAJAK C, Pao J, Ghuman A, McKevitt EC, et al
    Routine shave margins are not necessary in early stage breast cancer treated with Breast Conserving Surgery.
    Am J Surg. 2018 Jan 16. pii: S0002-9610(17)31640.
    PubMed     Text format     Abstract available


  26. SUTTON T, Reilly P, Johnson N, Garreau JR, et al
    Breast cancer in women under 50: Most are not high risk.
    Am J Surg. 2018 Jan 11. pii: S0002-9610(17)31563.
    PubMed     Text format     Abstract available


  27. LABGAA I, Slankamenac K, Schadde E, Jibara G, et al
    Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Am J Surg. 2018;215:125-130.
    PubMed     Text format     Abstract available


  28. RHEE D, Pockaj B, Wasif N, Stucky CC, et al
    Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies.
    Am J Surg. 2018;215:151-154.
    PubMed     Text format     Abstract available


    December 2017
  29. HEELAN GLADDEN AA, Sams S, Gleisner A, Finlayson C, et al
    Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines.
    Am J Surg. 2017;214:1104-1109.
    PubMed     Text format     Abstract available


  30. VELAZCO CS, Wasif N, Pockaj BA, Gray RJ, et al
    Radioactive seed localization for breast conservation surgery: Low positive margin rate with no learning curve.
    Am J Surg. 2017;214:1091-1093.
    PubMed     Text format     Abstract available


  31. CHANG JM, Kosiorek HE, Wasif N, Gray RJ, et al
    The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review.
    Am J Surg. 2017;214:1096-1101.
    PubMed     Text format     Abstract available


    November 2017
  32. TSUNG K, Grobmyer SR, Tu C, Abraham J, et al
    Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2017 Nov 14. pii: S0002-9610(17)30998.
    PubMed     Text format     Abstract available


  33. QU LT, Peters S, Cobb AN, Godellas CV, et al
    Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment.
    Am J Surg. 2017 Nov 13. pii: S0002-9610(17)31018.
    PubMed     Text format     Abstract available


    October 2017
  34. ABBOTT AM, Valente SA, Loftus L, Tendulkar RD, et al
    A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
    Am J Surg. 2017;214:629-633.
    PubMed     Text format     Abstract available


  35. BUCKLEY EJ, Zahnd WE, Rea DJ, Mellinger JD, et al
    Impact of rural-urban status on survival after mastectomy without reconstruction versus mastectomy with reconstruction.
    Am J Surg. 2017;214:645-650.
    PubMed     Text format     Abstract available


  36. NURUDEEN S, Guo H, Chun Y, Coopey S, et al
    Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
    Am J Surg. 2017;214:687-694.
    PubMed     Text format     Abstract available


    September 2017
  37. CHAGPAR A
    Discussion of Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 30. pii: S0002-9610(17)31379.
    PubMed     Text format    


  38. CHAGPAR AB
    On baseball and breast cancer.
    Am J Surg. 2017 Sep 20. pii: S0002-9610(17)31086.
    PubMed     Text format     Abstract available


  39. CHAGPAR AB, Horowitz N, Sanft T, Wilson LD, et al
    Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 19. pii: S0002-9610(17)30420.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: